MoneyWorks4Me

Venus Remedies - Quaterly Results

30 Oct 2021 Evaluate
The Turnover for the quarter ended September 2021 of Rs. 1926.43 millions increase by 62.69% from Rs. 1184.08 millions.The Net Profit of the company vaulted to 229.39% to Rs. 241.28  millions from Rs. 73.25 millions in the previous quarter.Operating Profit saw a handsome growth to 308.97 millions from 169.01 millions in the quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1926.43 1184.08 62.69 3294.91 2981.18 10.52 5146.23 3202.31 60.70
Other Income 29.63 117.39 -74.76 48.81 132.46 -63.15 177.62 35.79 396.28
PBIDT 308.97 169.01 82.81 521.77 392.05 33.09 646.25 466.47 38.54
Interest 0.00 73.33 -100.00 0.00 101.27 -100.00 127.26 130.46 -2.45
PBDT 308.97 171.62 80.03 521.77 275.02 89.72 753.41 247.89 203.93
Depreciation 84.58 83.47 1.33 168.25 166.80 0.87 342.80 310.51 10.40
PBT 224.39 88.15 154.55 353.52 108.22 226.67 410.61 -62.62 -755.72
TAX -16.89 14.90 -213.36 -33.66 14.90 -325.91 -132.12 19.64 -772.71
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 241.28 73.25 229.39 387.18 93.32 314.89 542.73 -82.26 -759.77
Equity 133.67 123.42 8.30 133.67 123.42 8.30 123.42 123.42 0.00
PBIDTM(%) 16.04 14.27 12.37 15.84 13.15 20.42 12.56 14.57 -13.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..